NeoLight, LLC

NeoLight, LLC is a health care startup that has garnered attention with its emphasis on empathy-driven innovation. Founded in 2014 and headquartered in the United States, the company is dedicated to developing best-in-class technologies for treating preventable conditions in the newborn care market. With a mission to set new standards in newborn care, NeoLight introduced its flagship product, the Skylife™ Phototherapy System, designed to treat neonatal jaundice, a condition prevalent among newborns worldwide. The cutting-edge Skylife™ device epitomizes the company's commitment to prioritizing the well-being of infants in its product design and development. Notably, the company secured a significant $2.82M Venture Round investment on 13 January 2022. The absence of specific details about the last_investment_investors suggests that the investor information may not be publicly disclosed at this time. NeoLight's innovative approach to addressing critical newborn care needs positions it as a promising player in the healthcare industry.